HFSA 2022: A Modern Approach to Heart Failure Treatment
This session from HFSA 2022 will explain what Cardiac Contractility Modulation therapy is, how it works, and the expected outcomes when utilizing this treatment for HF in NYHA Class III patients who remain symptomatic despite guideline directed medical therapy.
Dr. William Abraham discusses the challenges that continue to exist in the treatment of heart failure and the unmet needs the provider community must face together (0:00 - 14:39).
Watch the video HERE.
Dr. Javed Butler breaks down the mechanism of action of CCM® therapy and provides an overview of both historical and ongoing clinical trials, as well as planned future studies (14:40 - 29:57).
Watch the video HERE.
Dr. Andrew Sauer talks about his experiences with CCM® therapy and approaches to identify appropriate candidates in patients with limited options available to improve their symptoms and quality of life (29:58 - 53:00).
Watch the video HERE.
Finally, a patient shares her personal experience and how CCM® has changed her life.
